| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2021 | Apr 2020 | Apr 2018 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.97B | 4.93B | 5.54B | 4.69B | 3.51B | 3.70B |
| Gross Profit | 2.43B | 2.31B | 2.40B | 2.04B | 1.48B | 1.58B |
| EBITDA | 1.02B | 778.70M | 883.10M | 609.70M | 337.30M | 331.00M |
| Net Income | 467.70M | 292.10M | 380.80M | 249.80M | -83.00M | 112.00M |
Balance Sheet | ||||||
| Total Assets | 6.07B | 5.13B | 4.45B | 4.14B | 3.79B | 3.15B |
| Cash, Cash Equivalents and Short-Term Investments | 359.80M | 252.20M | 358.60M | 336.80M | 457.00M | 448.00M |
| Total Debt | 2.33B | 1.86B | 1.45B | 1.45B | 1.43B | 826.50M |
| Total Liabilities | 3.68B | 3.14B | 2.58B | 2.83B | 2.57B | 1.90B |
| Stockholders Equity | 2.36B | 1.96B | 1.84B | 1.29B | 1.19B | 1.25B |
Cash Flow | ||||||
| Free Cash Flow | 292.60M | 531.70M | 415.00M | 159.20M | 276.50M | 114.80M |
| Operating Cash Flow | 669.20M | 943.40M | 682.20M | 482.40M | 496.90M | 273.30M |
| Investing Cash Flow | -730.70M | -1.21B | -387.40M | -123.50M | -289.90M | -237.50M |
| Financing Cash Flow | 91.00M | 161.90M | -297.60M | -479.20M | -278.70M | 49.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £817.01M | 8.94 | 7.83% | 6.51% | -1.35% | -12.67% | |
73 Outperform | £2.84B | 2.38 | 21.64% | ― | -6.43% | 52.93% | |
73 Outperform | £1.33B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
71 Outperform | £3.39B | 26.72 | 17.89% | 1.21% | 14.60% | 58.84% | |
65 Neutral | £1.59B | 6.72 | 105.88% | 3.99% | 4.39% | -1.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
47 Neutral | £704.39M | -7.96 | -90.46% | 4.48% | -30.52% | -2064.92% |